Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fate Therapeutics (FATE) Other Operating Expenses (2023 - 2024)

Historic Other Operating Expenses for Fate Therapeutics (FATE) over the last 4 years, with Q4 2024 value amounting to $14.7 million.

  • Fate Therapeutics' Other Operating Expenses changed N/A to $14.7 million in Q4 2024 from the same period last year, while for Sep 2025 it was $14.7 million, marking a year-over-year change of. This contributed to the annual value of $14.7 million for FY2024, which is 83685.0% up from last year.
  • According to the latest figures from Q4 2024, Fate Therapeutics' Other Operating Expenses is $14.7 million.
  • In the past 5 years, Fate Therapeutics' Other Operating Expenses registered a high of $14.7 million during Q4 2024, and its lowest value of -$2.0 million during Q1 2023.